Alfresa Holdings Corporation

2784.T
Medical Distribution
2026/02/18 Updated
Market Cap: $3.0B (¥454.4B)
Stock Price: $16.28 (¥2,501)
Exchange Rate: 1 USD = ¥153.61

Notice Regarding the Recording of Special Profit (Gain on Sales of Investment Securities)

Recorded a gain on sales of investment securities of 15,449 million yen in the third quarter of the fiscal year ending March 2026. The sale was intended to reduce policy-held shares and improve asset efficiency, with no impact on earnings guidance.

Importance:
Page Updated: February 10, 2026
IR Disclosure Date: February 10, 2026

Key Figures

  • Gain on Sales of Investment Securities: 15,449 million yen
  • Sale Period: 2025-10-09 to 2025-12-08
  • Sale Targets: Three Listed Securities

AI要約

Overview of Sales of Investment Securities

Alfresa Holdings Corporation sold three listed securities from October 9, 2025 to December 8, 2025 aimed at reducing policy-held shares and enhancing asset efficiency. As a result, a gain on sales of investment securities of 15,449 million yen was recorded in the cumulative consolidated period of Q3 of the fiscal year ending March 2026.

Future Outlook

The recorded gain on sales of investment securities has been incorporated into the full-year earnings guidance for the fiscal year ending March 2026 announced on November 6, 2025, and no revisions to the earnings forecast are currently planned. Any future disclosures will be made promptly as necessary.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.